These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24421535)

  • 1. Cannabinoid hyperemesis syndrome.
    Sun S; Zimmermann AE
    Hosp Pharm; 2013 Sep; 48(8):650-5. PubMed ID: 24421535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cannabinoid hyperemesis syndrome: A review of the literature].
    Desjardins N; Stheneur C
    Arch Pediatr; 2016 Jun; 23(6):619-23. PubMed ID: 27017363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid hyperemesis syndrome: a review of the literature.
    Deceuninck E; Jacques D
    Psychiatr Danub; 2019 Sep; 31(Suppl 3):390-394. PubMed ID: 31488758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid hyperemesis syndrome: a case series and review of previous reports.
    Nicolson SE; Denysenko L; Mulcare JL; Vito JP; Chabon B
    Psychosomatics; 2012; 53(3):212-9. PubMed ID: 22480624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid hyperemesis syndrome.
    Galli JA; Sawaya RA; Friedenberg FK
    Curr Drug Abuse Rev; 2011 Dec; 4(4):241-9. PubMed ID: 22150623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis Hyperemesis Syndrome: A Still Under-Recognized Syndrome.
    Attout H; Amichi S; Josse F; Appavoupoule V; Randriajohany A; Thirapathi Y
    Eur J Case Rep Intern Med; 2020; 7(5):001588. PubMed ID: 32399447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergency Department Treatment of Cannabinoid Hyperemesis Syndrome: A Review.
    Khattar N; Routsolias JC
    Am J Ther; 2018; 25(3):e357-e361. PubMed ID: 28953512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cannabinoid hyperemesis syndrome should be considered by recurrent vomiting].
    Nordholm-Carstensen A
    Ugeskr Laeger; 2014 Nov; 176(45):. PubMed ID: 25394844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome.
    Venkatesan T; Levinthal DJ; Li BUK; Tarbell SE; Adams KA; Issenman RM; Sarosiek I; Jaradeh SS; Sharaf RN; Sultan S; Stave CD; Monte AA; Hasler WL
    Neurogastroenterol Motil; 2019 Jun; 31 Suppl 2(Suppl 2):e13606. PubMed ID: 31241817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid Hyperemesis Syndrome During Pregnancy: A Case Report.
    Andrews KH; Bracero LA
    J Reprod Med; 2015; 60(9-10):430-2. PubMed ID: 26592070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid hyperemesis syndrome: literature review and proposed diagnosis and treatment algorithm.
    Wallace EA; Andrews SE; Garmany CL; Jelley MJ
    South Med J; 2011 Sep; 104(9):659-64. PubMed ID: 21886087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid Hyperemesis Syndrome: Reports of Fatal Cases.
    Nourbakhsh M; Miller A; Gofton J; Jones G; Adeagbo B
    J Forensic Sci; 2019 Jan; 64(1):270-274. PubMed ID: 29768651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid hyperemesis syndrome: Clinical trajectories and patterns of use three months following a visit to the emergency department.
    Wightman RS; Metrik J; Lin TR; Collins AB; Beaudoin FL
    Acad Emerg Med; 2024 May; 31(5):463-470. PubMed ID: 37387520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid hyperemesis and the cyclic vomiting syndrome in adults: recognition, diagnosis, acute and long-term treatment.
    Blumentrath CG; Dohrmann B; Ewald N
    Ger Med Sci; 2017; 15():Doc06. PubMed ID: 28400711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Antiemetics in the Management of Pediatric Cannabinoid Hyperemesis Syndrome.
    Geraci E; Cake C; Mulieri KM; Fenn NE
    J Pediatr Pharmacol Ther; 2023; 28(3):222-227. PubMed ID: 37303765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid Hyperemesis Syndrome: Pathophysiology and Treatment in the Emergency Department.
    Richards JR
    J Emerg Med; 2018 Mar; 54(3):354-363. PubMed ID: 29310960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of droperidol in the treatment of cannabinoid hyperemesis syndrome.
    Lee C; Greene SL; Wong A
    Clin Toxicol (Phila); 2019 Sep; 57(9):773-777. PubMed ID: 30729854
    [No Abstract]   [Full Text] [Related]  

  • 18. Cannabinoid hyperemesis syndrome presentation to the emergency department: A two-year multicentre retrospective chart review in a major urban area.
    Hernandez JM; Paty J; Price IM
    CJEM; 2018 Jul; 20(4):550-555. PubMed ID: 28835305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Systematic Review on Cannabis Hyperemesis Syndrome and Its Management Options.
    Senderovich H; Patel P; Jimenez Lopez B; Waicus S
    Med Princ Pract; 2022; 31(1):29-38. PubMed ID: 34724666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid hyperemesis syndrome in two French emergency departments: a prospective cohort.
    Weiss J; Torrents R; Verhamme B; Roch A; Lazerges P; Jego M; Michelet P; Simon N
    Fundam Clin Pharmacol; 2021 Feb; 35(1):186-191. PubMed ID: 32564375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.